NCT01063868: A Long-term Safety Study With Tapentadol ER and Oxycodone CR in Patients With Moderate to Severe Pain Due to Chronic, Painful Diabetic Peripheral Neuropathy (DPN) |
|
|
| Terminated | 3 | 47 | US | Tapentadol extended release (ER), Oxycodone controlled release (CR) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Grünenthal GmbH | Diabetic Neuropathy, Painful, Diabetic Polyneuropathy | 04/10 | 06/10 | | |
